Company Filing History:
Years Active: 2003-2012
Title: Sandra Eickernjager: Innovator in Nucleic Acid Research
Introduction
Sandra Eickernjager is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid molecules and their applications in medicine. With a total of 2 patents, her work focuses on the adhesion of bacteria to human cells, which has important implications for vaccine development and diagnostics.
Latest Patents
Eickernjager's latest patents describe nucleic acid molecules that encode proteins mediating the adhesion of bacteria of the genus Neisseria to human cells. These patents also detail the proteins encoded by these nucleic acid molecules and the antibodies directed against them. Furthermore, her work includes pharmaceutical compositions, vaccines, and diagnostic compositions that incorporate these nucleic acid molecules, proteins, and antibodies.
Career Highlights
Sandra Eickernjager is affiliated with the Max Planck Society for the Advancement of Science, where she conducts her research. Her innovative work has positioned her as a key figure in the study of bacterial adhesion and its implications for human health.
Collaborations
Eickernjager has collaborated with notable scientists such as Thomas F. Meyer and Thomas Rudel, contributing to the advancement of research in her field.
Conclusion
Sandra Eickernjager's contributions to nucleic acid research and her innovative patents highlight her role as a leading inventor in the scientific community. Her work continues to pave the way for advancements in medical applications and diagnostics.